Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
|
Add to portfolio |
|
|
|
| Price: |
$20.90
| | Metrics |
| OS: |
250.6
|
M
| |
|
|
| Market cap: |
$5.24
|
B
| |
|
|
|
Net debt:
|
$61.9
|
M
| |
|
|
|
EV:
|
$5.3
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 130.5 | 78.9 | 90.9 | 78.6 | 93.5 | 90.7 | 92.8 | 60.6 |
| Revenue growth | 65.4% | -13.2% | 15.6% | -15.9% | 3.0% | -2.2% | 53.1% | 115.0% |
| Cost of goods sold | 0.3 | 46.3 | 56.3 | 53.5 | 58.8 | 46.6 | 39.3 | 37.2 |
| Gross profit | 130.2 | 32.6 | 34.6 | 25.1 | 34.7 | 44.2 | 53.5 | 23.4 |
| Gross margin | 99.8% | 41.3% | 38.0% | 31.9% | 37.1% | 48.7% | 57.6% | 38.6% |
| Selling, general and administrative | 269.3 | 137.0 | 135.1 | 126.1 | 59.1 | 47.8 | 45.2 | 38.0 |
| Research and development | | | | | 65.3 | 67.6 | 60.4 | 48.2 |
| EBITA | -138.7 | -58.1 | -44.2 | -101.0 | -89.8 | -71.2 | -29.1 | -62.9 |
| EBITA margin | -106.3% | -73.6% | -48.7% | -128.4% | -96.1% | -78.5% | -31.4% | -103.7% |
| Amortization of intangibles | 0.4 | | | | | | | |
| EBIT | -139.1 | -58.1 | -44.2 | -101.0 | -89.8 | -71.2 | -29.1 | -62.9 |
| EBIT margin | -106.6% | -73.6% | -48.7% | -128.4% | -96.1% | -78.5% | -31.4% | -103.7% |
| Pre-tax income | -274.9 | 29.4 | -84.1 | -102.6 | -92.2 | -74.4 | -31.7 | -66.2 |
| Income taxes | -93.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 34.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -181.2 | 29.4 | -84.1 | -102.6 | -92.2 | -74.4 | -31.7 | -66.2 |
| Net margin | -138.9% | 37.3% | -92.6% | -130.4% | -98.6% | -82.0% | -34.2% | -109.2% |
| |
| Diluted EPS | ($0.89) | $0.17 | ($0.55) | ($0.76) | ($0.87) | ($0.83) | ($0.42) | ($0.94) |
| Shares outstanding (diluted) | 204.1 | 175.0 | 152.5 | 135.1 | 105.7 | 89.1 | 75.6 | 70.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|